BRKR

Bruker Corporation

BRKR, USA

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

https://www.bruker.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

0.05

Next Payout:

Jan 2, 2026

Yield:

0.4432 %
BRKR
stock
BRKR

BRKR Stock: Barclays Raises Price Target to $55 with Overweight GuruFocus

Read more →
BRKR
stock
BRKR

JP Morgan Raises Price Target for BRKR to $55, Maintains Overwei GuruFocus

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$48.8333

Analyst Picks

Strong Buy

5

Buy

2

Hold

7

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

2.82

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-2.45 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.93 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-6.29 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.62

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 58.41% of the total shares of Bruker Corporation

1.

T. Rowe Price Investment Management,Inc.

(7.5341%)

since

2025/06/30

2.

BlackRock Inc

(7.3036%)

since

2025/06/30

3.

Vanguard Group Inc

(6.8758%)

since

2025/06/30

4.

Pallas Capital Advisors LLC

(6.2624%)

since

2025/06/30

5.

FMR Inc

(5.5404%)

since

2025/06/30

6.

Orbis Allan Gray Ltd

(3.0834%)

since

2025/06/30

7.

London Company of Virginia

(2.6521%)

since

2025/06/30

8.

State Street Corp

(2.4945%)

since

2025/06/30

9.

AQR Capital Management LLC

(2.1927%)

since

2025/06/30

10.

OZ Management LLC

(2.0266%)

since

2025/06/30

11.

Brown Advisory Holdings Inc

(1.81%)

since

2025/06/30

12.

Citadel Advisors Llc

(1.7878%)

since

2025/06/30

13.

Geode Capital Management, LLC

(1.3568%)

since

2025/06/30

14.

Dimensional Fund Advisors, Inc.

(1.2801%)

since

2025/06/30

15.

Goldman Sachs Group Inc

(1.2707%)

since

2025/06/30

16.

Morgan Stanley - Brokerage Accounts

(1.1354%)

since

2025/06/30

17.

Fidelity International Ltd

(1.1212%)

since

2025/06/30

18.

Edmond de Rothschild Holding S.A.

(0.9924%)

since

2025/06/30

19.

Vaughan Nelson Scarbrgh & Mccullough LP

(0.8527%)

since

2025/06/30

20.

Ameriprise Financial Inc

(0.8374%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(1.5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(2)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(2)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2.5)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.